Immunic receives European patent for vidofludimus calcium dosing regimens

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/28/2026

1. ON
2. SYNA
3. SPY
4. MU
5. AAPL
6. VEON
7. DRI
8. NVDA
9. FDXF
10. RKLB

Go back to Immunic receives European patent for vidofludimus calcium dosing regimens
(NASDAQ: IMUX) Delayed: 15.30 +0.23 (1.53%)
Previous Close $15.07    52 Week High $ 
Open $14.97    52 Week Low $ 
Day High $15.84    P/E N/A 
Day Low $14.87    EPS $ 
Volume 235,404